Gen \u0130la<\/strong>\u00e7<\/strong>\u00a0ve S\u0131hhat Eserleri Sanayi ve Ticaret A. \u015e.\u2019nin (GEN) hisselerinin halka arz\u0131 i<\/strong>\u00e7<\/strong>in yapt\u0131\u011f\u0131 izahname ba\u015fvurusu Sermaye Piyasas\u0131 \u015euras\u0131 (SPK) taraf\u0131ndan onayland\u0131. GEN halka arz\u0131, OYAK Yat\u0131r\u0131m\u00a0<\/strong>liderli\u011finde sabit fiyatla talep toplama sistemiyle 28-29-30 Temmuz 2021 tarihleri ortas\u0131nda ger\u00e7ekle\u015ftirilecek.<\/strong>\u00a0Halka arzda yurt i\u00e7i ferdi yat\u0131r\u0131mc\u0131lar i<\/strong>\u00e7<\/strong>in oransal da\u011f\u0131t\u0131m y<\/strong>\u00f6<\/strong>ntemi uygulanacak.<\/strong><\/p>\n GEN halka arz\u0131nda sermaye art\u0131r\u0131m\u0131 ve ortak sat\u0131\u015f\u0131 yoluyla toplam 62,5 milyon TL nominal k\u0131ymetli hissenin sat\u0131lmas\u0131 planlan\u0131yor. Fazla talep gelmesi halinde 6,3 milyon TL nominal pahal\u0131 hisselerin da ek sat\u0131\u015f kapsam\u0131nda halka arza bahis edilmesi ile halka arz\u0131n toplam b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fcn 68,8 milyon TL\u2019ye ula\u015fmas\u0131 bekleniyor. GEN \u0130la\u00e7\u2019\u0131n 1 TL nominal bedelli hissesinin halka arz fiyat\u0131 ise 10,75 TL olarak belirlenmi\u015ftir. Halka arz edilen hisselerin %34\u2019\u00fc Yurt \u0130\u00e7i Ki\u015fisel Yat\u0131r\u0131mc\u0131lara, %1\u2019i \u015eirket \u00c7al\u0131\u015fanlar\u0131na, %35\u2019i Yurt \u0130\u00e7i Kurumsal Yat\u0131r\u0131mc\u0131lara ve %30\u2019u Yurt D\u0131\u015f\u0131 Kurumsal Yat\u0131r\u0131mc\u0131lara tahsis edilmi\u015ftir.<\/p>\n GEL\u0130R\u0130N Y\u00dcZDE 70\u2019\u0130 YURT \u0130\u00c7\u0130 VE YURT DI\u015eI B\u00dcY\u00dcMEYE HARCANACAK<\/strong><\/p>\n GEN, halka arz sonras\u0131 elde edilecek gelirin %60-70\u2019lik k\u0131sm\u0131n\u0131 yurt i\u00e7i ve yurt d\u0131\u015f\u0131 b\u00fcy\u00fcmeyi sa\u011flayacak a\u015f\u0131 ve ila\u00e7 \u00fcretimi alanlar\u0131nda \u015firket sat\u0131n al\u0131mlar\u0131 ve yeni fabrika yat\u0131r\u0131mlar\u0131nda kullanmay\u0131 planlamaktayken, gelirin %15-20\u2019sini halihaz\u0131rda devam eden yat\u0131r\u0131mlar\u0131n finansman\u0131nda kullanmay\u0131, %10-15\u2019ini i\u015fletme sermayesi muhta\u00e7l\u0131\u011f\u0131 i\u00e7in ve tekrar kalan %10-15\u2019ini ise yeni eser geli\u015ftirme ve pazar ara\u015ft\u0131rmalar\u0131na aktarmay\u0131 hedeflemektedir.<\/p>\n GEN, \u00f6n\u00fcm\u00fczdeki 3 y\u0131l i\u00e7inde s\u00fcrat kesmeden yapt\u0131\u011f\u0131 yat\u0131r\u0131mlarla tecr\u00fcbelerini aktard\u0131klar\u0131 eserlerinin y\u00fczde 70\u2019ini ihra\u00e7 etmeyi hedefliyor. 2020 y\u0131l\u0131nda birinci FDA (ABD \u0130la\u00e7 ve Besin Dairesi) onay\u0131 i\u00e7in ba\u015fvuran GEN\u2019in T\u00fcrkiye\u2019de 34, Azerbaycan\u2019da 22, Kazakistan\u2019da 13, Rusya\u2019da 1 adet, Filipinler\u2018de 2 Endonezya\u2019da 2 adet ruhsatl\u0131 eseri bulunuyor.<\/p>\n ENDER HASTALIKLARDA AKLA GELEN B\u0130R\u0130NC\u0130 F\u0130RMA<\/strong><\/p>\n 1998 y\u0131l\u0131nda az hastal\u0131klar\u0131 oda\u011f\u0131na alarak yola \u00e7\u0131kan GEN, yenilik\u00e7i ve bahad\u0131r bir vizyonla geli\u015ftirdi\u011fi eserleri ve projeleri ile T\u00fcrk ila\u00e7 kesiminde k\u0131ymetli bir role sahip. GEN 40.000 m2 alana sahip GMP (\u0130yi \u00dcretim Uygulamalar\u0131) sertifikal\u0131 \u00fcretim tesisi, tecr\u00fcbeli AR-GE tak\u0131m\u0131 ve g\u00fc\u00e7l\u00fc global i\u015f ortaklar\u0131 ile T\u00fcrkiye\u2019de az hastal\u0131klar\u0131n tahlilinde akla birinci gelen firma olma \u00f6zelli\u011fini ta\u015f\u0131yor.<\/p>\n GEN, s\u0131hhat ve ila\u00e7 b\u00f6l\u00fcm\u00fcne yenilik\u00e7i tahliller kazand\u0131rmak ismine yapt\u0131\u011f\u0131 global i\u015ftiraklerini ve yat\u0131r\u0131mlar\u0131n\u0131 pandemi s\u00fcrecinde de devam ettirdi. Bug\u00fcne kadar yat\u0131r\u0131mlar\u0131na yakla\u015f\u0131k 52 milyon dolarl\u0131k bir kaynak ay\u0131ran GEN, bu yat\u0131r\u0131mlar\u0131n\u0131n y\u00fczde 75\u2019ini \u00f6z kaynak kullanarak ger\u00e7ekle\u015ftirdi. T\u00fcrkiye\u2019nin en s\u00fcratli b\u00fcy\u00fcyen ila\u00e7 firmalar\u0131ndan biri olan GEN, 2021 y\u0131l\u0131n\u0131n birinci \u00e7eyre\u011finde de son y\u0131llardaki b\u00fcy\u00fcme trendini yakalamay\u0131 ba\u015fard\u0131.<\/p>\n GEN, T\u00dcRK\u0130YE\u2019Y\u0130 \u0130LA\u00c7 B\u00d6L\u00dcM\u00dcN\u00dcN GELECE\u011e\u0130NE DAVET ED\u0130YOR<\/strong><\/p>\n 23 y\u0131ld\u0131r T\u00fcrk ila\u00e7 b\u00f6l\u00fcm\u00fcndeki kar\u015f\u0131lanmam\u0131\u015f s\u0131hhat gereksinimlerine, az hastal\u0131klara ve \u00f6zel tedavi alanlar\u0131na y\u00f6nelik yenilik\u00e7i eser ve tahlilleriyle \u00f6ne \u00e7\u0131kan GEN, hem yerli \u00fcretime katk\u0131 sa\u011fl\u0131yor hem de stratejik i\u015ftirakleri ile globaldeki alan\u0131n\u0131 g\u00fc\u00e7lendiriyor. Halka arz s\u00fcrecinde edinece\u011fi yeni ortaklarla b\u00f6l\u00fcmdeki g\u00fcc\u00fcn\u00fc katlamay\u0131 hedefleyen GEN, T\u00fcrkiye\u2019yi ila\u00e7 b\u00f6l\u00fcm\u00fcn\u00fcn gelece\u011fine davet ediyor.<\/p>\n<\/p>\n Para Tahlil<\/span><\/p>\n Gen \u0130la\u00e7\u00a0ve S\u0131hhat Eserleri Sanayi ve Ticaret A. \u015e.\u2019nin (GEN) hisselerinin halka arz\u0131 i\u00e7in yapt\u0131\u011f\u0131 izahname ba\u015fvurusu Sermaye Piyasas\u0131 \u015euras\u0131 …<\/p>\n","protected":false},"author":1,"featured_media":12617,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[2261,436,719,55,179],"class_list":["post-12616","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-borsa","tag-gen","tag-halka-arz","tag-ilac","tag-turk","tag-urun"],"yoast_head":"\n